Syndax Pharmaceuticals (SNDX) EBIT Margin Growth (5y) (2020 - 2026)
Syndax Pharmaceuticals (SNDX) EBIT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 583,793.00 |
| Mar 31, 2026 | 711,429.00 |
| Dec 31, 2025 | 513,531.00 |
| Sep 30, 2025 | 511,307.00 |
| Jun 30, 2025 | 419,988.00 |
| Mar 31, 2025 | 356,626.00 |
| Dec 31, 2024 | 248,341.00 |
| Sep 30, 2024 | 275,278.00 |
| Jun 30, 2024 | 193,601.00 |
| Dec 31, 2021 | 372,843.00 |
| Sep 30, 2021 | 483,419.00 |
| Jun 30, 2021 | -306,206.00 |
| Mar 31, 2021 | -429,718.00 |
| Dec 31, 2020 | -369,222.00 |
| Sep 30, 2020 | -331,760.00 |
| Jun 30, 2020 | 2.82 Mn |